Used early in the programming process, PERTS can fundamentally improve the integrity of the system as well as shorten programming projects.
PERTS is one of the industry's most accepted tools for "worst-case" scheduling analysis for both single-node and distributed real-time architectures.
The FDA has issued guidelines on currently available PERTS
for manufacturers to submit NDAs due to substantial variations in formulation, dosage and manufacture of current pancreatic enzyme products.
RapidBuild brings functional design, timing data collection and valuable PERTS Rate Monotonic Analysis (RMA) schedulability analysis together.
RapidBuild and PERTS are trademarks or registered trademarks of Tri-Pacific Software, Inc.
RapidSched and PERTS
are trademarks or registered trademarks of Tri-Pacific Software, Inc.